Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma
2016 ◽
Vol 175
(5)
◽
pp. 860-867
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 6568-6568
2010 ◽
Vol 20
(2)
◽
pp. 153-160
◽
Keyword(s):
2019 ◽